Invention Grant
US09562039B2 Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both β2 adrenergic receptor agonist and M3 muscarinic receptor antagonist activities
有权
具有β2肾上腺素能受体激动剂和M3毒蕈碱受体拮抗剂活性的2-氨基-1-羟乙基-8-羟基喹啉-2（1H） - 酮衍生物的盐
- Patent Title: Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both β2 adrenergic receptor agonist and M3 muscarinic receptor antagonist activities
- Patent Title (中): 具有β2肾上腺素能受体激动剂和M3毒蕈碱受体拮抗剂活性的2-氨基-1-羟乙基-8-羟基喹啉-2（1H） - 酮衍生物的盐
-
Application No.: US14770206Application Date: 2014-02-27
-
Publication No.: US09562039B2Publication Date: 2017-02-07
- Inventor: Montserrat Julia Jane , Francesc Carrera Carrera , Maria Prat Quiñones , Carlos Puig Duran , Francesca Pajuelo Lorenzo , Juan Antonio Perez Andres
- Applicant: ALMIRALL, S.A.
- Applicant Address: ES Barcelona
- Assignee: Almirall, S.A.
- Current Assignee: Almirall, S.A.
- Current Assignee Address: ES Barcelona
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Priority: EP13382060 20130227
- International Application: PCT/EP2014/053871 WO 20140227
- International Announcement: WO2014/131851 WO 20140904
- Main IPC: C07D409/14
- IPC: C07D409/14 ; A61K31/4709 ; A61K45/06 ; A61K9/00 ; C07C59/255 ; C07C309/05 ; C07D275/06
Abstract:
The present invention is directed to crystalline addition salts of (i) 8-hydroxyquinolin-2(1H)-one derivatives and (ii) a hydroxycarboxylic acid, a sulfonic acid or a sulfimide, or a pharmaceutically acceptable solvates thereof.
Public/Granted literature
Information query
